PFIZER INC 4

Pfizer Chairman & CEO Albert Bourla received 24 phantom stock units as deferred compensation, linked to Pfizer common stock, while his directly held common stock position remained 772,901 shares.

On July 15, 2026, Pfizer Inc. Chairman & CEO Albert Bourla acquired 24 phantom stock units under Pfizer’s Nonfunded Deferred Compensation and Supplemental Savings Plan, with each unit representing the economic value of one share of common stock to be settled in cash upon his separation from service. These units, linked to Pfizer’s common stock (approximate reference price $24.82 per share), increased his deferred compensation balance rather than his directly held share ownership, and can be reallocated by him into alternative investment options within the plan. Following this grant, his directly reported common stock holdings total 772,901 shares, representing a substantial ongoing equity-based interest aligned with shareholder value but with this specific transaction best characterized as routine deferred compensation rather than an open‑market trade.

Filing Facts

CIK

78003

Ticker

PFE

Form

4

Source Type

fda

Accession

0001225208-26-006638

Alert Tier

4